Rebirth 1999: Opening the Age of Black Technology Chapter 637

Bristol-Myers Squibb headquarters in the United States.

Bristol-Myers Squibb has performed very well during this time.

In addition to the traditional sales of medicines and equipment, the most important thing is to cooperate with Changtian Technology to set up a severe lung disease treatment center in Maple Leaf Country, which is running very well.

So far, thousands of patients have been successfully treated, and the total revenue will soon exceed 1 billion meters.

This is a real money printing machine.

Although the 2007 financial report has not yet come out, Bristol-Myers Squibb can confirm that the revenue and profit of the group company last year will definitely hit a record high.

Such achievements are inseparable from the cooperation between Changtian Technology.

Although there were some unpleasant things between Bristol-Myers Squibb's Vice President Cassian and Changtian Technology during the first negotiation, the final result was good, so Cassian was highly valued by the group company.

In 2008, Mr. Burgat, the CEO of the group company, will retire.

Whether it is the senior management of the group company or the board of directors, they all hope that Cassian can be elected as the head of Bristol-Myers Squibb Company.

Becoming the head of Bristol-Myers Squibb Company means having more resources and better wealth.

If nothing else, it is the intensive care center that cooperates with Changtian Technology. Those brokers who are related to the company's internal executives can get quite a lot of commissions for introducing a major customer to treatment by way of cutting the queue.

If Cassian can be successfully elected as the CEO of Bristol-Myers Squibb, the profit behind it is self-evident.

Western pharmaceutical companies.

Everything is business.

Just as Cassian was planning for a future campaign.

Bristol-Myers Squibb suddenly received an urgent letter from Changtian Technology.

In the letter, the Department of Social Security is requested to make every effort to supply osimertinib to Changtian Technology within one week.

If Bristol-Myers Squibb cannot complete the corresponding work in accordance with the requirements of Longsky Technology, Longsky Technology will immediately terminate the comprehensive cooperation with Bristol-Myers Squibb Company.

Seeing such a letter from Changtian Technology, Cassian's back felt a little cold.

As an executive of a pharmaceutical company, Xia Guo, through various efforts during this period, hopes to get osimertinib to be known by everyone.

Cassian also knows that the target of using osimertinib is not ordinary people, but experts of Xiaguo aircraft engine.

Although Osimertinib is still in the process of experimentation, from the current animal experiments and clinical experiments, the effect is quite good.

Therefore, many pharmaceutical giants and industry experts in the United States predict that after osimertinib is launched, it will definitely become the most popular targeted drug for advanced cancer in the world.

Now Changtian Technology has put pressure on Bristol-Myers Squibb in such a straightforward manner, which was not expected by Cassian.

At the beginning of the cooperation between Bristol-Myers Squibb and Changtian Technology, because Changtian Technology was in a strong position, the two parties did not sign any compensation for the sudden termination of the contract by Changtian Technology.

That is to say, in the process of cooperation between the two parties, Changtian Technology has always been in a strong position from the beginning to the end.

Changtian Technology can terminate the contract at any time and terminate the cooperation at any time without obtaining any compensation.

Now Changtian Technology is desperate to put pressure on Bristol-Myers Squibb, and it is obviously going out of his way.

This approach of Changtian Technology must be in violation of the relevant norms of the United States.

But whocare?

The one with the hard fist is the boss.

Income from intensive care centers has become Bristol-Myers Squibb's biggest profit point.

If Bristol-Myers Squibb Company loses such a big profit point, this is not worth the loss.

A lot of things are, if you can take tonics, but you can't take laxatives, it is difficult to spit them out in your mouth.

This letter requires a very tight schedule, and the corresponding drugs are provided within a week.

Cassian did not dare to make decisions without authorization, and immediately reported the relevant situation to the company's top management.

The senior management of Bristol-Myers Squibb Company held an emergency meeting. After discussion, all the senior management agreed that the Maple Leaf National Intensive Care Center, which was finally established, must not be cancelled arbitrarily.

Bristol-Myers Squibb will elaborate all methods to get the relevant drugs from AstraZeneca.

Chen Xiao's guess was not wrong at all.

Several pharmaceutical giants in the United States restrict each other and cooperate with each other.

Bristol-Myers Squibb definitely has an ace that AstraZeneca fears.

Also received letters are Johnson & Johnson and Pfizer and other companies.

The situation of the two companies is the same as that of Bristol-Myers Squibb.

If the cooperation with Changtian Technology is lost because of this little trivial matter, this is really worth the loss.

Among them, Pfizer's annual profit in critical treatment in Mexico is already higher than some of Pfizer's branded drugs.

Merchants are chasing profits, and it is more painful for them to lose this profit than to cut flesh from their bodies.

Companies such as Pfizer acted urgently to start negotiations with AstraZeneca.

Ask AstraZeneca to provide osimertinib immediately.

Pfizer and AstraZeneca also have a lot of technology collaborations.

In terms of cancer-targeted drugs, the two parties actually share patents.

So now AstraZeneca is facing a dilemma.

On the one hand, there is pressure from the relevant departments in the United States, requiring AstraZeneca to prohibit the supply of any targeted drugs to Xia Guo.

On the other hand, this is the pressure from American capital.

The capital behind the pharmaceutical companies represented by Pfizer, Johnson & Johnson, and Bristol-Myers Squibb is a requirement that AstraZeneca can immediately provide relevant drugs as soon as possible, in order to quell the anger from Xia Guochangtian's technology.

American politics is for capital.

All political decisions are made to allow capital to proliferate better.

So AstraZeneca has little choice but to compromise with capital.

He provided osimertinib to all three companies for the first time.

The reason for this, AstraZeneca still has its own considerations.

Even if the relevant departments of the United States are offended and fined, such losses are much more cost-effective than offending Bristol-Myers Squibb Johnson & Johnson, the three giant companies of Pfizer and the capital behind them.

AstraZeneca's volume is placed there, and there are many patents for medicines and equipment in hand.

It is absolutely impossible for the relevant departments of the United States to make AstraZeneca disappear because of this incident.

At this moment, on Tianyue Island in Xia Country, the intensive care center.

Qu Ping's team is nervously completing the combined colony and lung resection for He Jiang.

He Jiang's lungs are quite fragile.

Long-term bed rest increased his chances of lung infection.

If the lungs are not removed at this time, even if the combined colony surgery is successful, the infection of the lungs will make He Jiang critically ill.

Therefore, Qu Ping's team, together with the relevant medical staff of Fudan University Cancer Center, took the risk and urgently performed the operation on He Jiang.

The leaders and colleagues of the 606 Institute are not happy in their hearts.

They originally came this time in the hope that He Jiang could explain some technical work.

Who knew that on the day I saw He Jiang, He Jiang lay in bed and couldn't say a word at all.

Colleagues at the 606 Institute can feel that He Jiang is eager to communicate with everyone, but his physical condition does not allow it.

So they can only hope that the operation will be successful now.

If the operation cannot be successful, even if my turbofan 10 engine can be finally perfected, I don't know that it will be in the year of the monkey.

The Institute is already in a race against time.

Relevant departments of Xia Guo. Also learned that the country is undergoing surgery.

And the news from He Jiang's treatment team at Fudan University Affiliated Hospital is that the chance of He Jiang's surgery being successful is very low, and the leaders of the relevant departments are requested to prepare for the worst.

After Liang Fei got the news, his heart was very heavy, and his heart was extremely angry.

He felt that some things should not be hidden.

Why does this situation happen to He Jiang?

The most critical reason is that many domestic pharmaceutical scientific research institutions are overstaffed, all trying to make money and defrauding scientific research funds, and no one can sink their hearts into scientific research.

Regarding the establishment of cancer-targeted drugs, the project actually existed 20 years ago.

However, in the past 20 years, where the scientific research projects have been established, the number of people who are actually engaged in related scientific research is very small.

Why?

This somewhat deformed scientific research environment is inseparable.

A scientific research that lasts for more than 10 years, if you do not produce any achievements in the end, these 10 years of time will be wasted, and the funding will be wasted.

Which of the experts and researchers who can stand in the experiments of scientific research institutes is not the top of the pyramid?

After studying hard for decades, I finally came to this position. Of course, I wanted to make as much money as possible.

Therefore, many quick-acting projects are hard-working.

And those projects that need to settle down and move forward one step at a time are simply uninterested.

This is why Xia Guo's Internet applications can be greatly developed in a short period of time, and targeted drugs similar to anti-cancer and chip technology are the fundamental reasons for the stagnation.

Because of the development of Internet applications, it is possible to obtain huge benefits in a very short period of time.

And making chips or making targeted drugs for cancer, it is very likely that they have worked hard and anonymously for decades, without any results, only hard work and no return.

Liang Fei reported this matter to the senior executives of Yanjing, and hoped that Xia Guo TV could truthfully announce He Jiang's deeds and related situations.

The purpose of this is to inspire Xia Guo's scientific researchers, especially those young people who are about to enter the scientific research industry.

We must recognize the severe situation that Xia Guo is currently facing in the high-end pharmaceutical industry, and encourage everyone not to care about temporary gains and losses, and to do research with peace of mind.

Most of the elites in Xia Guo made some short-term projects.

After a project is completed, there may be tens of millions of income soon.

But if you really settle down, do your research well, and make breakthroughs in projects such as cancer-targeted drugs that require long-term scientific research and investment, then the mobile phone you get may be hundreds of millions or even tens of billions of meters.

The rose of time is especially fragrant in scientific research projects, but many people are reluctant to wait.

After being instructed by the relevant departments, about He Jiang's obscurity for decades, the deeds of making turbofan 10 engines, and the United States doing everything possible to block domestic access to targeted drugs such as osimertinib. And other related news is reported in Xia Guo overwhelmingly.

In addition to Xiaguo TV, heavyweight paper media such as "Huanhuan Times", "Shenxiao", and "Yanjing Daily", as well as online media such as Xinlang and Huohu, are reporting crazily.

Countless ordinary people in the Xia Kingdom felt very angry when they saw such news, and they were worried and anxious about He Jiang's condition.

"The white-skinned pig is so bad! In order to kill one of our engineers, the diagnosis has done everything possible to ban the sale of drugs!"

"I also saw a lot of anger, but I can't say the same thing. All the current measures of the US companies are in line with the relevant requirements of the US. After all, targeted drugs for advanced cancers like ositril are originally in the experimental process. There is no external sales, and even if they are sold externally, they have no cooperation agreement with us, so it is normal that the other party does not provide drugs."

"I feel very sad! The Chinese people have to rely on the medicine of the foreigners for their own lives!"

"Extremely angry! Why can't we produce a drug with the same efficacy?"

"I fully understand the feeling upstairs, but the production of anticancer drugs is not a simple matter. It involves many industries, especially the life science industry. Our country has a major difference with the United States in basic science. The foundation is decades behind, let alone such a high-end scientific and technological achievement.”

"What about Changtian Technology? Isn't Changtian Technology very good? Why can't we save Professor He Jiang?"

"Please use your brain when you speak upstairs. Changtian Technology has only been established for a few years? It is quite remarkable to be able to achieve today's achievements! You can't ask a private company to fight alone and compete with the elite team of the entire United States! "

"Agree with the speech upstairs! When making sarcastic sarcasm at Changtian Technology, you should think about the many pharmaceutical companies and research institutes in the state of Xia, who receive so much state funding every year, yet dare not let go of a fart!"

At this time, Chang Zezhou in Suzhou and Hangzhou.

The coping strategies given by Chen Xiao are indeed very effective.

Whether it is Bristol-Myers Squibb, Pfizer, Johnson & Johnson and other companies, they provided Changtian Technology with osimertinib, which is currently in the trial stage, at the first time.

And these companies have guaranteed Changtian Technology, UU reading www. All the medicines of uukanshu.com are from AstraZeneca, the medicines are sufficient, and there are no legal and economic risks.

When Qu Ping was the first to get the news, she excitedly trotted to Chen Xiao's office to report to Chen Xiao.

Qu Ping knew about He Jiang's situation, and it was very likely that after taking osimertinib, it could not be completely cured, and could only prolong his life as much as possible.

But this medicine is better than nothing.

Chen Xiao didn't seem too happy when he got such news.

He had expected such an outcome.

After all, under the huge profits, the three pharmaceutical companies that were notified will definitely do everything possible.

However, Chen Xiao felt that this kind of method of hitting hard with fists should be done less often.

Changtian Technology still needs to be more powerful. It is so powerful that as long as you raise your fist, it will make others feel afraid, instead of letting the other party try your fist hard.

United States, an intelligence agency.

Bellito, who was in charge of the He Jiang project, slammed on the table angrily after learning that Changtian Technology had obtained the drug!

Bellito believes that what Changtian Technologists do is to fly above their own heads!

(https://)

Set a small goal first, such as 1 second to remember: Shukeju mobile version reading website:

Chapter end

Report